Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,134

Participants

Timeline

Start Date

June 26, 2020

Primary Completion Date

March 24, 2021

Study Completion Date

March 31, 2024

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Nasal Swab

Collection of one more nasal swabs

DIAGNOSTIC_TEST

Nasopharyngeal swab

Collection of one more nasopharyngeal swabs

DIAGNOSTIC_TEST

Throat swab

Collection of one more throat swabs

DIAGNOSTIC_TEST

Fingerstick

Collection of capillary blood from one or more fingersticks

DIAGNOSTIC_TEST

Saliva specimen

Collection of free drool

Trial Locations (7)

21108

Gvozden Pediatrics, Millersville

27103

Ardmore Family Practice, Winston-Salem

30318

Good Samaritan Minute Clinic, Georgia Tech, Atlanta

32701

Children's Pediatric Associates of Altamonte Springs, Altamonte Springs

34744

Chappel Group, Kissimmee

38305

Physicians Quality Care of Jackson, Jackson

75024

Village Health Partners, Plano

All Listed Sponsors
lead

LumiraDx UK Limited

INDUSTRY